Synapse - Works

Results (607)

Correlation of minimal residual disease (MRD) at the end of induction (EOI) and event free survival (EFS) in T-cell lymphoblastic lymphoma (T-LL), a report from the children's oncology group (COG) trial AALL1231

Meeting Abstract

Hayashi, R. J.; Hermiston, M. L.; Teachey, D. T.; Devidas, M.; Wood, B. L.; Chen, Z.; Annett, R. D.; Asselin, B. L.; August, K. J.; Cho, S. Y.; more...
Blood (2022)

Fulltext@MSK | Save

Unmatched whole-genome sequencing as a clinical tool for hematological neoplasms with significant utility in cases with tumor-in-normal contamination

Meeting Abstract

Gutiérrez-Abril, J.; Leongamornlert, D.; Shukla, N. N.; Sulis, M. L.; Zhou, Y.; Levine, M. F.; Barretta, E.; Lee, S.; Arango-Ossa, J. E.; Gundem, G.; more...
Blood (2022)

Fulltext@MSK | Save

The menin inhibitor SNDX-5613 (revumenib) leads to durable responses in patients (Pts) with KMT2A-rearranged or NPM1 mutant AML: Updated results of a phase (Ph) 1 study

Meeting Abstract

Issa, G. C.; Aldoss, I.; DiPersio, J. F.; Cuglievan, B.; Stone, R. M.; Arellano, M. L.; Thirman, M. J.; Patel, M. R.; Dickens, D.; Shenoy, S.; more...
Blood (2022)

Fulltext@MSK | Save

Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets

Meeting Abstract

Nacev, B. A.; Sanchez-Vega, F.; Smith, S.; Antonescu, C.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N.; Rana, S.; Gularte-Merida, R.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

Outcomes of MSK-NY-II therapy in pediatric and young adult patients with precursor B-cell acute lymphoblastic leukemia

Meeting Abstract

Ramaswamy, K.; Forlenza, C.; Shukla, N.; Trippett, T.; Sulis, M. L.; Steinherz, P.
Pediatric Blood and Cancer (2022)

Fulltext@MSK | Save

Reducing empiric antibiotic administration in pediatric oncology patients with non-neutropenic fever: A single center quality improvement initiative

Meeting Abstract

Satty, A.; Stiefel, J.; Bernot, M. R.; Hudda, Z.; Llaurador, G.; Lakkaraja, M.; Mauguen, A.; Seo, S.; Glade-Bender, J.; Sulis, M. L.; more...
Pediatric Blood and Cancer (2022)

Fulltext@MSK | Save

Venetoclax in pediatric and young adult patients with relapsed/refractory solid tumors: Updated findings from a phase 1 study

Meeting Abstract

Morgenstern, D.; Khaw, S.; Gerber, N.; Place, A.; Corradini, N.; Loh, M.; Verschuur, A.; Ziegler, D.; Fraser, C.; Cooper, T.; more...
Pediatric Blood and Cancer (2022)

Fulltext@MSK | Save

Efficacy and safety of daratumumab (DARA) in pediatric and young adult patients (pts) with relapsed/refractory T-cell acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL): Results from the phase 2 DELPHINUS study

Meeting Abstract

Hogan, L. E.; Bhatla, T.; Teachey, D. T.; Sirvent, F. J. B.; Moppett, J.; Puyó, P. V.; Micalizzi, C.; R?Ssig, C. R.; Shukla, N.; Gilad, G.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Quantitative cell proteomic atlas: Pathway-scale targeted mass spectrometry for high-resolution functional profiling of cell signaling

Journal Article

Cifani, P.; Kentsis, A.
Journal of Proteome Research (2022)

Fulltext@MSK | Save

Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: A Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)

Journal Article

Tasian, S. K.; Silverman, L. B.; Whitlock, J. A.; Sposto, R.; Loftus, J. P.; Schafer, E. S.; Schultz, K. R.; Hutchinson, R. J.; Gaynon, P. S.; Orgel, E.; more...
Haematologica (2022)

Fulltext@MSK | Save